Please login to the form below

Not currently logged in
Email:
Password:

Pfizer sued for off-label Lipitor marketing

A former Pfizer official accuses the company of illegally boosting sales of its top-selling drug Lipitor through misleading medical educational programmes for doctors

A former Pfizer official has accused the company of illegally boosting sales of its top-selling drug Lipitor (atorvastatin) through misleading medical educational programmes for doctors.

The allegations against Pfizer concern continuing medical-education programmes for doctors, which are often sales pitches for "off-label" uses of drugs.

Dr Jesse Polansky, claims that the educational campaign was a key part of a marketing strategy which persuaded thousands of doctors to prescribe Lipitor for millions of patients who did not need the drug and could have been harmed as a result.

The lawsuit was filed in US District Court for the Eastern District of New York in February 2004. Pfizer was served a copy of the suit on 19 December, according to Dr Polansky's lawyer, Steve Berman of Hagens Berman Sobol Shapiro.

Pfizer said in a statement: "We believe this case has no meritÖPfizer does not condone the off-label promotion of our products. We believe that our sales and marketing practices are solely based on our prescription information as approved by the FDA."

Polansky was Pfizer's director of outcomes management strategies from 2001 to 2003. As part of his role, he reviewed some of the marketing materials for Lipitor and other Pifzer products.

Polansky claims Pfizer fired him when he complained about marketing he considered to be improper. He now works as the senior medical officer for Medicare in a unit that investigates fraud and abuse at the big government health insurer.

The suit seeks compensation for Polansky as a whistleblower. Federal laws in the US mean he could win a share of money recovered for any overpayments made by federal health-insurance programmes.

The lipid-lowering drug Lipitor is the world's biggest-selling treatment and racked up FY06 sales of USD 13.6bn, according to IMS Health data.

20th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics